Name: Living with Narcolepsy: Saturday Support Group
Start: 2025-02-01T13:30:00-05:00
End: 2025-02-01T14:30:00-05:00
Location: HeyPeers Website

Jul 20 2022
Avadel Pharmaceuticals: FDA grants tentative approval to LUMRYZ

Posted at Jul 20 2022
h in News by Chris DavisAdvertising

Avadel Pharmaceuticals announced today that the FDA has granted tentative approval to LUMRYZ, a once-at-bedtime investigational formulation of sodium oxybate for the treatment of excessive daytime sleepiness (EDS) or cataplexy in adults with narcolepsy.

Read Article

Print page

Jul 20 2022 Avadel Pharmaceuticals: FDA grants tentative approval to LUMRYZ

0 events, 29

0 events, 29

2 events, 30

2 events, 30

1 event, 31

1 event, 31

2 events, 1

2 events, 1

1 event, 2

1 event, 2

1 event, 3

1 event, 3

1 event, 4

1 event, 4

0 events, 5

0 events, 5

2 events, 6

2 events, 6

1 event, 7

1 event, 7

2 events, 8

2 events, 8

1 event, 9

1 event, 9

1 event, 10

1 event, 10

1 event, 11

1 event, 11

0 events, 12

0 events, 12

2 events, 13

2 events, 13

1 event, 14

1 event, 14

2 events, 15

2 events, 15

1 event, 16

1 event, 16

1 event, 17

1 event, 17

1 event, 18

1 event, 18

0 events, 19

0 events, 19

2 events, 20

2 events, 20

1 event, 21

1 event, 21

2 events, 22

2 events, 22

1 event, 23

1 event, 23

1 event, 24

1 event, 24

1 event, 25

1 event, 25

0 events, 26

0 events, 26

2 events, 27

2 events, 27

1 event, 28

1 event, 28

Jul 20 2022
Avadel Pharmaceuticals: FDA grants tentative approval to LUMRYZ